Login / Signup

Impact of chronic oral glucocorticoid treatment on mortality in patients with COVID-19: analysis of a population-based cohort.

Margret Jona EinarsdottirBrian K KiruiHuiqi LiDaniel S OlssonGudmundur JohannssonFredrik NybergOskar Ragnarsson
Published in: BMJ open (2024)
Patients on oral GC treatment prior to COVID-19 have increased mortality, particularly from pulmonary embolism, sepsis and COVID-19.
Keyphrases
  • pulmonary embolism
  • coronavirus disease
  • sars cov
  • ejection fraction
  • newly diagnosed
  • intensive care unit
  • risk factors
  • acute kidney injury
  • coronary artery disease
  • mass spectrometry
  • replacement therapy